| Danvers,
Mass., September 14, 2005—ABIOMED, Inc. (NASDAQ: ABMD)
announced today that Michael R. Minogue, Chairman, President and Chief
Executive Officer, will present at the ThinkEquity Partners Annual
Growth Conference on September 15, 2005 at 11:30 a.m. PST. The conference
will be held at the Ritz Carlton in San Francisco.
A live webcast of the presentation will be made available on the
ABIOMED website www.abiomed.com. The webcast will be archived for
two weeks.
ABOUT ABIOMED
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced “AB’-EE-O-MED”)
is a leading developer, manufacturer and marketer of medical products
designed to assist or replace the pumping function of the failing
heart. ABIOMED currently manufactures and sells the AB5000™
Circulatory Support System and the BVS® 5000 Biventricular Support
System for the temporary support of all patients with failing but
potentially recoverable hearts. In Europe, ABIOMED offers the Impella®
Recover™ minimally invasive cardiovascular support systems
under CE Mark approval. The Company’s AbioCor® Implantable
Replacement Heart was the subject of an initial clinical trial under
an Investigational Device Exemption from the United States Food
and Drug Administration. The AbioCor has not been approved for commercial
distribution, and is not available for use or sale outside of the
initial clinical trial. For additional information please visit:
www.abiomed.com.
###
Contacts:
Liza Heapes
ABIOMED, INC.
Communications Specialist
(978) 646-1668
mediarelations@abiomed.com
Investor Relations Contact:
Rx Communications Group, LLC
Melody A. Carey
(917) 322-2571
mcarey@rxir.com
|
